SOURCE: Fresh Start Private Management, Inc.

Fresh Start Private Management,  Inc.

February 05, 2014 08:00 ET

Fresh Start Private Management, Inc. Includes North Carolina in Recent Letter of Intent With Current Licensee

LOS ANGELES, CA--(Marketwired - Feb 5, 2014) - Fresh Start Private Management, Inc. (OTCQB: CEYY), a leader in alcohol treatment and rehabilitation programs, announced it has amended a recent letter of intent dated January 27, 2014 to sell the exclusive license and distribution rights of its Start Fresh Program to Fresh Start NoCal, LLC. Under the terms of the pending agreement, Fresh Start NoCal, LLC will agree to pay Fresh Start Private an upfront licensing fee plus an upfront fee per program order in the states of Maryland, Virginia, West Virginia, North Carolina, and the District of Columbia. Fresh Start NoCal currently has the rights to Northern California in a transaction that was completed in 2013.

With the addition of North Carolina, the population of this territory is now close to 26.5 million people. This region of the country is densely populated, allowing many people to be treated within a relatively small geographic area.

"Fresh Start NoCal is very excited to partner with us and members of their group expressed keen interest in North Carolina due to strategic alliances there. They know our program and believe in our program and they want to move very fast," said Kent Emry, CEO of Fresh Start Private Management, Inc. "Our goal is widespread distribution of our program quickly and this will help tremendously since they don't have a learning curve to get through."

Recent Media

About Fresh Start Private (Soon to be BioCorRx. Inc.)

Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, visit

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Contact Information

  • Investor Relations Contact:
    Maximum Performance Advisors, Inc.